High-throughput Screening Market Financial Overview and Growth Prospects Predicted by 2027 from priya Raut's blog

High Throughput Screening (HTS) is an automated drug-discovery process that is typically utilized in the pharmaceutical business. It uses mechanization to identify active compounds, genes, or antibodies in a relatively short time frame. The technique has its use in the initial stages of drug discovery pathway and in toxicology studies. 

The high throughput screening market was worth USD 13,460 million in 2018 and is expected to grow at a CAGR of 7.5% during the forecast period. 

Market Research Future’s (MRFR) extensive and in-depth study of the global High-Throughput Screening market reveals that it will grow at an impressive rate during the assessment period of 2017-2027. Mounting investments in the healthcare sector and the shifting inclination towards high throughput research is pushing the growth of the market. The HTS market, globally, is largely driven by efficacy & safety screening, target identification & validation, and monitoring of cell-based activity. Some of the additional pointers that would support the growth of the market are the rising drug discovery initiatives by academic and government institutions, huge acceptance of open innovation models by pharmaceutical organizations. 

Market Segmentation

The market segmentation of High-throughput Screening is segmented on the following basis: application, product, and end-users.

By application, the market includes Toxicology, Target Identification, Stem Cell Biology, Primary Screening, and others. 

By products, the market comprises consumables, software, instruments, and others. 

By end-users, the market includes pharmaceutical companies/manufacturers, government organizations, Hospitals and clinics, research facilities, and others

Regional Analysis

The regional market segmentation of High-throughput Screening market is divided into North America, Europe, Asia-Pacific, and the Middle East & Africa.

The North American region is the global geographical market leader of high-throughput screening and is expected to grow at an impressive CAGR of XX% during the forecast period. The demanding R&D initiatives undertaken herein is the major factor that is driving the market growth of this region. High expenditure in healthcare coupled with substantial investments from government and private entities for R& purposes are sure to push the market reach of the North American region. 

Europe is the second-largest market and is projected to grow at a substantially fast-paced CAGR percentage during the forecast period. Government support and initiatives are some of the major reasons accelerating the market push of Europe. Additionally, the booming pharmaceutical industry and a resurging economy are further adding fuel to the market potential. 

Competitive Analysis

The report also identifies some of the most prominent players in the global High-throughput Screening market, which includes Roche (Switzerland), Agilent Technologies Inc. (US), Beckman Coulter, Inc. (US), Thermo Fisher Scientific, Inc. (US), Life Technologies Corporation (US), Aurora Biomed Inc. (Canada), Bio-Rad Laboratories (US), Luminex Corporation (US), and Sigma-Aldrich Corporation. (US).

Browse Full Report Details @  https://www.marketresearchfuture.com/reports/high-throughput-screening-market-1280


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Previous post     
     Next post
     Blog home

The Wall

No comments
You need to sign in to comment